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Background
Group 2 innate lymphoid cells (ILC2) are characterized by
their expression of cytokines including IL-5 and IL-13 in
response to IL-33. ILC2 are critical in mediating influenza
virus-induced airway hypersensitivity and are associated
with allergic inflammation. However, the factors regulating
human ILC2 (hILC2) cytokine responses are not fully
defined. In this study, we tested the hypothesis that prosta-
glandin I2 (PGI2), a lipid product formed in the cyclooxy-
genase (COX) pathway of arachidonic acid metabolism,
suppresses IL-33-induced cytokine responses by hILC2.
Methods
hILC2 (Lin-CD25+CD127+ cells) were purified by flow
cytometric cell sorting from peripheral blood mononuc-
lear cells and stimulated with IL-33 and IL-2 in the pre-
sence of the PGI2 analog cicaprost or vehicle.
Results
We found that hILC2 expressed the IL-33 receptor and
the PGI2 receptor IP. Treatment of the cells with cicaprost
significantly decreased IL-5 and IL-13 production, and the
inhibition was associated with lower levels of mRNA
expression of the transcription factors involved in the pro-
duction of these cytokines and ILC2 development includ-
ing gata3, gfi-1, Ror-a and Id2. cAMP-elevating reagents
such as db-cAMP and PGE2 had a similar inhibitory effect
on IL-5 and IL-13 production by hILC2.
Conclusions
These data indicate that PGI2 inhibits hILC2 cytokine
secretion and suggest that use of COX inhibiting drugs
may increase the risk of developing allergic diseases by
augmenting ILC2 cytokine responses.
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